Home » medical research » Regulators push openness agenda on raw trial data…and EUPATI issues call for examples of educational materials on medicines development

Regulators push openness agenda on raw trial data…and EUPATI issues call for examples of educational materials on medicines development

Welcome

Thanks for visiting my blog. I am Chair of INVOLVE - the UK's national advisory group on public involvement - and NIHR National Director for Public Participation and Engagement in Research. I was CEO at the Association of Medical Research Charities (AMRC) from 2006 until 2011. My full profile can be found on the 'Biography' page. The views on here are all personal ones unless otherwise stated. I hope you enjoy some of the things I write and/or find a useful link or two along the way.

Yes, that is a long headline is it not? 

PharmaTimes and others cover a paper in PloS Medicine authored by a number of medicines regulators including the European Medicines Agency (EMA), calling for openness in raw trial data. The three pronged approach they suggest looks like a good basis for discussion.  It would be interesting to know whether patient groups or charities have made any response to their suggestions.

Meanwhile, the European Patients’ Academy on Therapuetic Innovation (EUPATI) has issued a call for examples of educational materials on medicines development.  EUPATI is a new initiative launched earlier this year to improve patient-facing materials on medicines R&D.

About these ads

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: